Skip to main content

Ɔltin bɔt di Anifrolumab vaysin fɔ lupus, insay simpul wɔd dɛn

Ɔltin bɔt di Anifrolumab vaysin fɔ lupus, insay simpul wɔd dɛn

If yu gɛt lupus, yu dɔktɔ go dɔn tɛl yu bɔt wan nyu mɛrɛsin. Dɛn kɔl am anifrolumab. Di nem kin tan lɛk se i kɔmplikt smɔl. Bɔt nɔ wɔri. Insay dis atikul, wi go tɔk bɔt di mɛrɛsin simpul, fayn fayn wan, aw i de wok, wetin i kin du, ɛn wetin yu nid fɔ no bɔt.

Wetin na Anifrolumab?

Fɔ tɔk am simpul wan, Anifrolumab na vaysin we dɛn kin gi fɔ trit sɔm kayn lupus. Naw, luk, wi bɔdi gɛt sɔntin we dɛn kɔl di imyun sistɛm. Di men wok we i de du na fɔ protɛkt wi frɔm sik dɛn bay we i de fɛt di jem ɛn vayrɔs dɛn we de kɔmɔt na do.

Bɔt, pan sik dɛn lɛk lupus, sɔntin kin rɔng. Dis imyun sistεm kin bi ova aktif εn bigin fכ atak wi כwn gud sεl dεm. I tan lɛk se wi yon ami de atak wi. Wetin di Anifrolumab vaysin de du na fɔ kɔntrol di spid we da ɔvaaktiv imyun sistɛm de de. Dɔn di inflamɛns ɛn ɔda sayn dɛm fɔ lupus kin go dɔŋ smɔl smɔl.

We wi de tɔk bɔt mɛrɛsin, dis na mɛrɛsin we de insay di grup we dɛn kɔl monoklɔnal antibodi . Dis drɔg de mɔs de na Sri Lanka ɛn di wɔl ɔnda di brand nem SAPHNELO .

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin

Bifo yu bigin dis tritmɛnt, i rili impɔtant fɔ tɔk to yu dɔktɔ opin wan bɔt yu kɔmplit wɛlbɔdi istri. Mek shɔ se yu tɛl dɛn bɔt ɛni wan pan dɛn tin ya, mɔ if dɛn aplay to yu. If yu ayd dɛn tin ya, dat kin ambɔg yu.

Di tin we de apin to yu Wetin mek dat impɔtant?
Kansa If yu gɛt kansa naw ɔ yu dɔn gɛt am trade, yu dɔktɔ fɔ no bɔt am.
Wan infɛkshɔn we dɔn deTɛl yu dɔktɔ bɔt ɛni infekshɔn, inklud vayral infɛkshɔn lɛk chikinpoks ɛn hεpi. Dis mɛrɛsin de stɔp di imyun sistɛm, we kin mek di infɛkshɔn wɔs.
Wan vaksin we dɛn jɔs dɔn gi ɔ we dɛn dɔn sɛtul fɔ gi (Vaccine) . Sɔm vaysin kin intarakt wit dis mɛrɛsin, so i impɔtant fɔ tɛl yu dɔktɔ bɔt dis.
Alɛji dɛn we pɔsin kin gɛt If yu gɛt ɛni alɛji to Anifrolumab ɔ ɛni ɔda mɛrɛsin, it, ɔ day, mek shɔ se yu tɛl yu dɔktɔ.
Fɔ gɛt bɛlɛ ɔ fɔ tray fɔ gɛt bɛlɛ If yu gɛt bɛlɛ ɔ yu de plan fɔ bɔn pikin, tɔk to yu dɔktɔ bifo yu bigin dis mɛrɛsin.
Fɔ gi pikin in mama in bɛlɛ If yu na mama we de gi pikin in mama in bɛlɛ, aks yu dɔktɔ bɔt aw dis mɛrɛsin go afɛkt yu pikin.

Aw yu kin yuz dis mɛrɛsin?

Dis nɔto mɛrɛsin we yu kin kɛr go na os. Anifrolumab na injεkshכn we dεn kin gi insay di b כdi tru wan vein (intravenous infusion) . Dis min se dɛn kin gi am na ɔspitul ɔ klinik, ɔnda di sɔpɔtishɔn fɔ dɔktɔ ɔ tren nɔs staf.

Wetin yu go du if yu mis wan doz?

If yu mis yu scheduled dose, nɔ skip am. Tɔk to yu dɔktɔ kwik kwik wan fɔ chenj di tɛm fɔ yu nɛks doz. Fɔ tek yu dos dɛn di rayt tɛm impɔtant fɔ mek yu tritmɛnt go bifo.

Wetin fɔ du if di mɛrɛsin doz go ɔp?

If yu tink se yu aksidɛntli tek dis mɛrɛsin pasmak, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta wantɛm wantɛm na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Ɔda mɛrɛsin dɛm wae kin miks wit dis mɛrɛsin (Drug Interactions) .

Sɔm mɛrɛsin kin mek yu gɛt prɔblɛm we yu tek am wit Anifrolumab, so i bɛtɛ fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek (inklud vaytamɛn ɛn ɛbul mɛrɛsin).

Tayp fɔ mɛrɛsin Tɔk bɔt
Nɔ tek Anifrolumab wit dɛn tin ya atɔl.
Layf vayrɔs vaysin dɛn Nɔ gɛt layf vayrɔs vaysin we yu de tek dis tritmɛnt.
Mek shɔ se yu tɛl yu dɔktɔ if yu de tek dis mɛrɛsin.
Bayolojikal drɔgs dɛn Ɛgzampul dɛn: Mɛdisin dɛn lɛk Adalimumab, Certolizumab, Etanercept, Golimumab, Infliximab.
Sayklɔfosfamid Dis na ɔda pawaful mɛrɛsin we de kɔntrol di imyuniti.
Ɔda Mɔnoklɔnal antibodi dɛn Ɛgzampul dɛn: Mɛdisin dɛn lɛk Belimumab, Ocrelizumab, Ofatumumab, Rituximab.

Tin dɛn we yu fɔ tink bɔt we yu de du tritmɛnt

  • Chek-ap ɔltɛm: We yu de tek dis mɛrɛsin, i impɔtant fɔ de chɛk-ap ɔltɛm lɛk aw yu dɔktɔ tɛl yu. Tɛl yu dɔktɔ if yu sik de wɔs ɔr de wɔs.
  • Wach ɔut fɔ infɛkshɔn: Dis mɛrɛsin de stɔp yu imyun sistɛm, so yu kin gɛt infɛkshɔn mɔ . So if yu gɛt sayn dɛn fɔ kol ɔ ɔda infekshɔn, lɛk fiva, kol, kɔf, trot we de at, pen we yu de pis, ɔ sɔri we nɔ de wɛl, nɔ fɔ mɛn yusɛf ɛn kɔl yu dɔktɔ fɔ advays. Tray fɔ de fa frɔm pipul dɛn we sik.
  • Tɔk bɔt di chans fɔ gɛt kansa: Sɔm kayn kansa kin go ɔp smɔl we yu de tek dis mɛrɛsin. Nɔr frayd fɔ dis, bɔt tɔk to yu dɔktɔ bɔt dis risk fɔ gɛt klia ɔndastandin.

Wetin na di bad tin dɛn we kin apin to pɔsin?

Lɛk ɛni mɛrɛsin, Anifrolumab kin mek sɔm pipul dɛn gɛt sayd ɛfɛkt. Bɔku pan dɛn tin ya nɔto siriɔs tin, bɔt sɔm tin dɛn de we wi fɔ no bɔt.

Sayd ɛfɛkt we pɔsin kin gɛt Wetin fɔ du?
If yu gɛt dɛn sik ya, tɛl yu dɔktɔ kwik kwik wan.
Alɛji we pɔsin kin gɛt Di sayn dɛm lɛk skin rash, it, ayv, swel na yu fes, lip, tɔng ɔ trot. Dɛn tin ya kin rili siriɔs.
Sayn dɛn we de sho se pɔsin gɛt di sik Fiva, kol, kɔf, trot we de at, wund we nɔ de wɛl, infekshɔn na di urinary tract, ɛn malaise.
Bɔku tɛm, dɛn tin ya nɔ kin siriɔs, bɔt if dɛn kɔntinyu fɔ de, tɛl yu dɔktɔ.
Kɔf Tɛl yu dɔktɔ if i kɔntinyu fɔ de ɔ i de mɔna yu.
Diziz (vɛrtigo) . Nɔ drayv ɔ yuz mashin te dis kɔndishɔn dɔn.
TayaGɛt inof rɛst. If i kɔntinyu fɔ de, tɔk to yu dɔktɔ.
Ed de at Yu kin go to yu dɔktɔ ɛn gɛt wan fayn mɛrɛsin fɔ mɛn yu pen.
Vɔmit It simpul it dɛn. Nɔ it tin dɛn we gɛt ɔyl ɛn we gɛt spays.
Trot de at If yu drink wam wam drink, dat kin mek yu fil fri.

If yu notis ɛnitin we nɔ kɔmɔn we nɔ de pan dis list, nɔ fred fɔ tɔk to yu dɔktɔ bɔt am bak.

Mɛsej we dɛn kin kɛr go na os

  • Anifrolumab na injɛkshɔn fɔ lupus we dɛn kin gi insay di bɛlɛ. Dɛn kin gi am na ɔspitul ɔ klinik.
  • Bifo yu bigin fɔ trit yu, mek shɔ se yu tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, ɛni ɔda sik we yu gɛt, ɛn if yu gɛt bɛlɛ.
  • Di risk kin go ɔp smɔl fɔ gɛt di sik we yu de tek dis mɛrɛsin, so if yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, tɛl yu dɔktɔ wantɛm wantɛm.
  • If yu gɛt alɛji lɛk di skin we de rɔsh, it, ɔ yu fes swel bikɔs ɔf di mɛrɛsin, na imejensi. Go to dɔktɔ wantɛm wantɛm.
  • If yu gɛt ɛni kwɛstyɔn bɔt dis mɛrɛsin, nɔ ɛva fred fɔ aks yu dɔktɔ. Yu gɛt ɔl di rayt fɔ no bɔt yu wɛlbɔdi biznɛs.

Anifrolumab, Lupus, SAPHNELO, lupus, imyun sistεm, monoklonal antibodi, sayd ifekt dεm

Frequently Asked Questions (FAQ)

Wetin yu go du if yu mis wan doz?

If yu mis yu scheduled dose, nɔ skip am. Tɔk to yu dɔktɔ kwik kwik wan fɔ chenj di tɛm fɔ yu nɛks doz. Fɔ tek yu dos dɛn di rayt tɛm impɔtant fɔ mek yu tritmɛnt go bifo.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 7 + 5 =
Ɔltin bɔt di Anifrolumab vaysin fɔ lupus, insay simpul wɔd dɛn

Ɔltin bɔt di Anifrolumab vaysin fɔ lupus, insay simpul wɔd dɛn

If yu gɛt lupus, yu dɔktɔ go dɔn tɛl yu bɔt wan nyu mɛrɛsin. Dɛn kɔl am anifrolumab. Di nem kin tan lɛk se i kɔmplikt smɔl. Bɔt nɔ wɔri. Insay dis atikul, wi go tɔk bɔt di mɛrɛsin simpul, fayn fayn wan, aw i de wok, wetin i kin du, ɛn wetin yu nid fɔ no bɔt.

Wetin na Anifrolumab?

Fɔ tɔk am simpul wan, Anifrolumab na vaysin we dɛn kin gi fɔ trit sɔm kayn lupus. Naw, luk, wi bɔdi gɛt sɔntin we dɛn kɔl di imyun sistɛm. Di men wok we i de du na fɔ protɛkt wi frɔm sik dɛn bay we i de fɛt di jem ɛn vayrɔs dɛn we de kɔmɔt na do.

Bɔt, pan sik dɛn lɛk lupus, sɔntin kin rɔng. Dis imyun sistεm kin bi ova aktif εn bigin fכ atak wi כwn gud sεl dεm. I tan lɛk se wi yon ami de atak wi. Wetin di Anifrolumab vaysin de du na fɔ kɔntrol di spid we da ɔvaaktiv imyun sistɛm de de. Dɔn di inflamɛns ɛn ɔda sayn dɛm fɔ lupus kin go dɔŋ smɔl smɔl.

We wi de tɔk bɔt mɛrɛsin, dis na mɛrɛsin we de insay di grup we dɛn kɔl monoklɔnal antibodi . Dis drɔg de mɔs de na Sri Lanka ɛn di wɔl ɔnda di brand nem SAPHNELO .

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin

Bifo yu bigin dis tritmɛnt, i rili impɔtant fɔ tɔk to yu dɔktɔ opin wan bɔt yu kɔmplit wɛlbɔdi istri. Mek shɔ se yu tɛl dɛn bɔt ɛni wan pan dɛn tin ya, mɔ if dɛn aplay to yu. If yu ayd dɛn tin ya, dat kin ambɔg yu.

Di tin we de apin to yu Wetin mek dat impɔtant?
Kansa If yu gɛt kansa naw ɔ yu dɔn gɛt am trade, yu dɔktɔ fɔ no bɔt am.
Wan infɛkshɔn we dɔn deTɛl yu dɔktɔ bɔt ɛni infekshɔn, inklud vayral infɛkshɔn lɛk chikinpoks ɛn hεpi. Dis mɛrɛsin de stɔp di imyun sistɛm, we kin mek di infɛkshɔn wɔs.
Wan vaksin we dɛn jɔs dɔn gi ɔ we dɛn dɔn sɛtul fɔ gi (Vaccine) . Sɔm vaysin kin intarakt wit dis mɛrɛsin, so i impɔtant fɔ tɛl yu dɔktɔ bɔt dis.
Alɛji dɛn we pɔsin kin gɛt If yu gɛt ɛni alɛji to Anifrolumab ɔ ɛni ɔda mɛrɛsin, it, ɔ day, mek shɔ se yu tɛl yu dɔktɔ.
Fɔ gɛt bɛlɛ ɔ fɔ tray fɔ gɛt bɛlɛ If yu gɛt bɛlɛ ɔ yu de plan fɔ bɔn pikin, tɔk to yu dɔktɔ bifo yu bigin dis mɛrɛsin.
Fɔ gi pikin in mama in bɛlɛ If yu na mama we de gi pikin in mama in bɛlɛ, aks yu dɔktɔ bɔt aw dis mɛrɛsin go afɛkt yu pikin.

Aw yu kin yuz dis mɛrɛsin?

Dis nɔto mɛrɛsin we yu kin kɛr go na os. Anifrolumab na injεkshכn we dεn kin gi insay di b כdi tru wan vein (intravenous infusion) . Dis min se dɛn kin gi am na ɔspitul ɔ klinik, ɔnda di sɔpɔtishɔn fɔ dɔktɔ ɔ tren nɔs staf.

Wetin yu go du if yu mis wan doz?

If yu mis yu scheduled dose, nɔ skip am. Tɔk to yu dɔktɔ kwik kwik wan fɔ chenj di tɛm fɔ yu nɛks doz. Fɔ tek yu dos dɛn di rayt tɛm impɔtant fɔ mek yu tritmɛnt go bifo.

Wetin fɔ du if di mɛrɛsin doz go ɔp?

If yu tink se yu aksidɛntli tek dis mɛrɛsin pasmak, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta wantɛm wantɛm na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Ɔda mɛrɛsin dɛm wae kin miks wit dis mɛrɛsin (Drug Interactions) .

Sɔm mɛrɛsin kin mek yu gɛt prɔblɛm we yu tek am wit Anifrolumab, so i bɛtɛ fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek (inklud vaytamɛn ɛn ɛbul mɛrɛsin).

Tayp fɔ mɛrɛsin Tɔk bɔt
Nɔ tek Anifrolumab wit dɛn tin ya atɔl.
Layf vayrɔs vaysin dɛn Nɔ gɛt layf vayrɔs vaysin we yu de tek dis tritmɛnt.
Mek shɔ se yu tɛl yu dɔktɔ if yu de tek dis mɛrɛsin.
Bayolojikal drɔgs dɛn Ɛgzampul dɛn: Mɛdisin dɛn lɛk Adalimumab, Certolizumab, Etanercept, Golimumab, Infliximab.
Sayklɔfosfamid Dis na ɔda pawaful mɛrɛsin we de kɔntrol di imyuniti.
Ɔda Mɔnoklɔnal antibodi dɛn Ɛgzampul dɛn: Mɛdisin dɛn lɛk Belimumab, Ocrelizumab, Ofatumumab, Rituximab.

Tin dɛn we yu fɔ tink bɔt we yu de du tritmɛnt

  • Chek-ap ɔltɛm: We yu de tek dis mɛrɛsin, i impɔtant fɔ de chɛk-ap ɔltɛm lɛk aw yu dɔktɔ tɛl yu. Tɛl yu dɔktɔ if yu sik de wɔs ɔr de wɔs.
  • Wach ɔut fɔ infɛkshɔn: Dis mɛrɛsin de stɔp yu imyun sistɛm, so yu kin gɛt infɛkshɔn mɔ . So if yu gɛt sayn dɛn fɔ kol ɔ ɔda infekshɔn, lɛk fiva, kol, kɔf, trot we de at, pen we yu de pis, ɔ sɔri we nɔ de wɛl, nɔ fɔ mɛn yusɛf ɛn kɔl yu dɔktɔ fɔ advays. Tray fɔ de fa frɔm pipul dɛn we sik.
  • Tɔk bɔt di chans fɔ gɛt kansa: Sɔm kayn kansa kin go ɔp smɔl we yu de tek dis mɛrɛsin. Nɔr frayd fɔ dis, bɔt tɔk to yu dɔktɔ bɔt dis risk fɔ gɛt klia ɔndastandin.

Wetin na di bad tin dɛn we kin apin to pɔsin?

Lɛk ɛni mɛrɛsin, Anifrolumab kin mek sɔm pipul dɛn gɛt sayd ɛfɛkt. Bɔku pan dɛn tin ya nɔto siriɔs tin, bɔt sɔm tin dɛn de we wi fɔ no bɔt.

Sayd ɛfɛkt we pɔsin kin gɛt Wetin fɔ du?
If yu gɛt dɛn sik ya, tɛl yu dɔktɔ kwik kwik wan.
Alɛji we pɔsin kin gɛt Di sayn dɛm lɛk skin rash, it, ayv, swel na yu fes, lip, tɔng ɔ trot. Dɛn tin ya kin rili siriɔs.
Sayn dɛn we de sho se pɔsin gɛt di sik Fiva, kol, kɔf, trot we de at, wund we nɔ de wɛl, infekshɔn na di urinary tract, ɛn malaise.
Bɔku tɛm, dɛn tin ya nɔ kin siriɔs, bɔt if dɛn kɔntinyu fɔ de, tɛl yu dɔktɔ.
Kɔf Tɛl yu dɔktɔ if i kɔntinyu fɔ de ɔ i de mɔna yu.
Diziz (vɛrtigo) . Nɔ drayv ɔ yuz mashin te dis kɔndishɔn dɔn.
TayaGɛt inof rɛst. If i kɔntinyu fɔ de, tɔk to yu dɔktɔ.
Ed de at Yu kin go to yu dɔktɔ ɛn gɛt wan fayn mɛrɛsin fɔ mɛn yu pen.
Vɔmit It simpul it dɛn. Nɔ it tin dɛn we gɛt ɔyl ɛn we gɛt spays.
Trot de at If yu drink wam wam drink, dat kin mek yu fil fri.

If yu notis ɛnitin we nɔ kɔmɔn we nɔ de pan dis list, nɔ fred fɔ tɔk to yu dɔktɔ bɔt am bak.

Mɛsej we dɛn kin kɛr go na os

  • Anifrolumab na injɛkshɔn fɔ lupus we dɛn kin gi insay di bɛlɛ. Dɛn kin gi am na ɔspitul ɔ klinik.
  • Bifo yu bigin fɔ trit yu, mek shɔ se yu tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, ɛni ɔda sik we yu gɛt, ɛn if yu gɛt bɛlɛ.
  • Di risk kin go ɔp smɔl fɔ gɛt di sik we yu de tek dis mɛrɛsin, so if yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, tɛl yu dɔktɔ wantɛm wantɛm.
  • If yu gɛt alɛji lɛk di skin we de rɔsh, it, ɔ yu fes swel bikɔs ɔf di mɛrɛsin, na imejensi. Go to dɔktɔ wantɛm wantɛm.
  • If yu gɛt ɛni kwɛstyɔn bɔt dis mɛrɛsin, nɔ ɛva fred fɔ aks yu dɔktɔ. Yu gɛt ɔl di rayt fɔ no bɔt yu wɛlbɔdi biznɛs.

Anifrolumab, Lupus, SAPHNELO, lupus, imyun sistεm, monoklonal antibodi, sayd ifekt dεm

Frequently Asked Questions (FAQ)

Wetin yu go du if yu mis wan doz?

If yu mis yu scheduled dose, nɔ skip am. Tɔk to yu dɔktɔ kwik kwik wan fɔ chenj di tɛm fɔ yu nɛks doz. Fɔ tek yu dos dɛn di rayt tɛm impɔtant fɔ mek yu tritmɛnt go bifo.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 7 + 5 =